Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


10th World Congress on Healthcare & Technologies

Lisbon, Portugal

Jennifer Reese

Jennifer Reese

University of Utah | USA

Title: Implementing Patient Reported Outcomes (PROs) for mental health screening throughout a healthcare system


Biography: Jennifer Reese


Objective: The use of Patient Reported Outcomes (PROs) to screen for mental health has traditionally been implemented through a manual process of paper and pencil with little standardization throughout a Healthcare System. Patients are typically screened when the provider identifies them as having a need; many patients are not screened. As we move forward into an era of health technology we can leverage this capability to provide a standardized health outcomes assessment using PROs for mental health screening to all patients. We investigate the rate of identification of depressive symptoms in patients before and after deployment of a standard technology-based screening.

Methods: The University of Utah has over 1 million ambulatory visits per year with over 400,000 unique patients. We currently administer the PROMIS Depression v1.0 instrument as part of a standard PRO assessment to all patients. We customize the time between consecutive repeated PRO assessments based on specialty preference to minimize patient burden, while maximizing relevant data for clinicians. Collected data resides within the electronic health record and is displayed in tabular and normalized graphical forms. We used ICD-10 codes to identify patients diagnosed with depression and anti-depressant prescription to identify treated patients. Summary statistics were generated using R (Version 3.3.2).

Results: At the end of year one, 48,926 patients were seen in practices that used the automated PROs and 16,046 unique patients were screened using an automated PRO platform. These patients generated 22,042 observed scores. A concurrent manual process of screening using the PHQ-2 or PHQ-9 was also used during this timeframe. In these practices, XXXX patients were seen. The PHQ-2 screened 2,543 unique patients with 2,904 scores and the PHQ-9 screened 7,289 patients generating 11,814 scores. There were 911 unique patients who received the automated PRO platform using PROMIS Depression and the PHQ-2 or PHQ-9. Of the patients screened, 1,297 were identified as at risk using the automated PRO platform, which accounts for 1.37% of the 94,488 eligible patient visits. With the manual process, 2,926 were identified as at risk, but this accounts for just 0.7% of the 408,926 eligible patient visits. When comparing the automated platform (PROMIS Depression) to the manual process (PHQ-9), the instruments agreed on the screening results 78% of the time. 66.4% of the patients identified as at risk for depression using the PROMIS Depression or using the PHQ-9 did not previously have a diagnosis of depression or prescription for an antidepressant.

Conclusions: The use of an automated PRO platform for mental health screening enables a clinician to identify patients at risk that may have otherwise gone undetected. Our automated platform was able to screen more unique patients in the same time frame as compared to a manual process even with implementation of the automated process in just under 50% of our total clinics’ appointments. By implementing PROs in all clinics, we hope to identify our total population of patients at risk for mental health issues.

Speaker Presentations

Speaker PPTs Click Here